GINGER ATKINSON: Open Payments
NPI 1982945762 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,703 in 97 payments from 19 companies in 2025. Trend: 2023 $3,542 · 2024 $3,563 · 2025 $2,703
Food & beverage: $2,531Education: $172
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $474 |
| ABBVIE INC. | 20 | $431 |
| GENZYME CORPORATION | 6 | $316 |
| Janssen Biotech, Inc. | 10 | $252 |
| LEO Pharma Inc. | 7 | $194 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $182 |
| Galderma Laboratories, L.P. | 9 | $140 |
| Amgen Inc. | 4 | $120 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
Products named: Bimzelx, DUPIXENT, RINVOQ, TREMFYA, ADBRY, SKYRIZI, NEMLUVIO, Otezla.
Industry payments across NC — which companies pay providers there.
